Nitric oxide: considerations for the treatment of ischemic stroke

被引：110

作者：

Terpolilli, Nicole A. ^{[2
]}

Moskowitz, Michael A. ^{[3
]}

Plesnila, Nikolaus ^{[1
]}

机构：

[1] Univ Munich, Sch Med, Inst Stroke & Dementia Res, Munich, Germany

[2] Univ Munich, Sch Med, Dept Neurosurg, Munich, Germany

[3] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Neurosci, Boston, MA USA

来源：

JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM | 2012年 / 32卷 / 07期

关键词：

acute stroke; experimental; focal ischemia; neuroprotection; nitric oxide; CEREBRAL-BLOOD-FLOW; HIGH-DENSITY-LIPOPROTEIN; COA REDUCTASE INHIBITOR; ENDOTHELIAL GROWTH-FACTOR; PROTEIN-KINASE AKT; RHO-KINASE; L-ARGININE; ARTERY OCCLUSION; RELAXING FACTOR; OBLIGATORY ROLE;

D O I：

10.1038/jcbfm.2012.12

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Some 40 years ago it was recognized by Furchgott and colleagues that the endothelium releases a vasodilator, endothelium-derived relaxing factor (EDRF). Later on, several groups identified EDRF to be a gas, nitric oxide (NO). Since then, NO was identified as one of the most versatile and unique molecules in animal and human biology. Nitric oxide mediates a plethora of physiological functions, for example, maintenance of vascular tone and inflammation. Apart from these physiological functions, NO is also involved in the pathophysiology of various disorders, specifically those in which regulation of blood flow and inflammation has a key role. The aim of the current review is to summarize the role of NO in cerebral ischemia, the most common cause of stroke. Journal of Cerebral Blood Flow & Metabolism (2012) 32, 1332-1346; doi: 10.1038/jcbfm.2012.12; published online 15 February 2012

引用

页码：1332 / 1346

页数：15

共 210 条

[51] Mechanisms of stroke protection by physical activity [J].

Endres, M ;

Gertz, K ;

Lindauer, U ;

Katchanov, J ;

Schultze, J ;

Schröck, H ;

Nickenig, G ;

Kuschinsky, W ;

Dirnagl, U ;

Laufs, U .

ANNALS OF NEUROLOGY, 2003, 54 (05) :582-590

[52] Stroke protection by 3-hydroxy-3-methylglutaryl (HMG)-CoA reductase inhibitors mediated by endothelial nitric oxide synthase [J].

Endres, M ;

Laufs, U ;

Huang, ZH ;

Nakamura, T ;

Huang, P ;

Moskowitz, MA ;

Liao, JK .

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (15) :8880-8885

[53] Subacute but not acute generation of nitric oxide in focal cerebral ischemia [J].

Fassbender, K ;

Fatar, M ;

Ragoschke, A ;

Picard, M ;

Bertsch, T ;

Kuehl, S ;

Hennerici, M .

STROKE, 2000, 31 (09) :2208-2211

[54] Inhaled prostacyclin, nitric oxide, and nitroprusside in pulmonary hypertension after mitral valve replacement [J].

Fattouch, K ;

Sbraga, F ;

Bianco, G ;

Speziale, G ;

Gucciardo, M ;

Sampognaro, R ;

Ruvolo, G .

JOURNAL OF CARDIAC SURGERY, 2005, 20 (02) :171-176

[55] INDUCIBLE BUT NOT CONSTITUTIVE PRODUCTION OF NITRIC-OXIDE BY VASCULAR SMOOTH-MUSCLE CELLS [J].

FLEMING, I ;

GRAY, GA ;

SCHOTT, C ;

STOCLET, JC .

EUROPEAN JOURNAL OF PHARMACOLOGY, 1991, 200 (2-3) :375-376

[56] Inhaled NO as a viable antiadhesive therapy for ischemia/reperfusion injury of distal microvascular beds [J].

Fox-Robichaud, A ;

Payne, D ;

Hasan, SU ;

Ostrovsky, L ;

Fairhead, T ;

Reinhardt, P ;

Kubes, P .

JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (11) :2497-2505

[57] Regulation of endothelium-derived nitric oxide production by the protein kinase Akt [J].

Fulton, D ;

Gratton, JP ;

McCabe, TJ ;

Fontana, J ;

Fujio, Y ;

Walsh, K ;

Franke, TF ;

Papapetropoulos, A ;

Sessa, WC .

NATURE, 1999, 399 (6736) :597-601

[58]

FURCHGOTT RF, 1987, BLOOD VESSELS, V24, P145

[59] THE OBLIGATORY ROLE OF ENDOTHELIAL-CELLS IN THE RELAXATION OF ARTERIAL SMOOTH-MUSCLE BY ACETYLCHOLINE [J].

FURCHGOTT, RF ;

ZAWADZKI, JV .

NATURE, 1980, 288 (5789) :373-376

[60] ENDOTHELIUM-DERIVED RELAXING FACTOR RELEASE ON ACTIVATION OF NMDA RECEPTORS SUGGESTS ROLE AS INTERCELLULAR MESSENGER IN THE BRAIN [J].

GARTHWAITE, J ;

CHARLES, SL ;

CHESSWILLIAMS, R .

NATURE, 1988, 336 (6197) :385-388

← 1 2 3 4 5 6 7 8 9 10 →